Welcome to the e-CCO Library!

P761 Illness cognition of Saudi patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.H.A. Mosli, A. Saeedi, M. ALNEFAIE, N. Bawahab, L. Abdu, S. Shobai

Created: Thursday, 30 January 2020, 10:12 AM
P761: Gene expression differences between Crohn's disease aphthous ulcers and healthy Peyer's patches highlights potential treatment strategies
Year: 2017
Source: ECCO '17 Barcelona
Authors:

O'Brien C.*1,2, Patel H.3, Freeman T.4, Zhang K.5, Peng K.5, Pavli P.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P761: Healthcare quality assessment in inflammatory bowel disease Units in Spain under patient’s perspective. IQCARO project
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

X. Calvet1, D. Carpio2, M. Minguez3, I. Vera4, L. Marin5, R. Saldaña6, B. Juliá*7, L. Cea7, F. Casellas8

Created: Friday, 22 February 2019, 9:41 AM
P761: IFX dose-escalation strategy based on a population PK model in IBD patients with secondary loss of response
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Guardiola1*, L. Rodriguez Alonso1, K. Serra1, E. Santacana2, H. Colom3, F. Rodríguez-Moranta1, P. Gilabert1, C. Arajol1, E. Sanchez Pastor1, J. Bas4, A. Padullés2, N. Padullés2

Created: Thursday, 21 February 2019, 9:14 AM
P761: Negative Body Image in Inflammatory Bowel Disease persists despite Modern IBD care
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Madigan, S.(1);Prichard, I.(2);Smart, C.(1);Prosser, R.(1);Mountifield, R.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P762 Prevalence association between HPV and fistulising perianal Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. RODRIGUES BOARINI1, C.W. Sobrado Jr1, V.R. Guzela1, A. Pozzebon Gonçalves1, L. Lina Villa2, S.R. Nadal3, A. Da Costa Lino Costa4, S.C. Nahas1

Created: Thursday, 30 January 2020, 10:12 AM
P762: Gene expression profiling of immune adaptive response in the colonic mucosa from patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Fonseca Camarillo G., Iturriaga Goyon E., Yamamoto Furusho J.K.

Created: Wednesday, 20 February 2019, 10:36 AM
P762: GO-CARE: A prospective multi-centre observational study of golimumab effectiveness and quality of life in a real-life UC patient population in Italy
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Armuzzi1*, S. Marchi2, A. Gasbarrini3, S. Saibeni4, A. Geccherle5, M. Principi6, V. Germano7, F. Bossa8, A.C. Privitera9

Created: Thursday, 21 February 2019, 9:14 AM
P762: Onset of inflammatory bowel disease during treatment with secukinumab: Can anti-IL-17A be a trigger for inflammatory bowel disease?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Rodríguez Moncada*1, J. M. Vázquez Morón1, M. Rojas Feria2, J. M. Herrera Justiniano3, B. Maldonado Pérez4, M. Castro Fernández2, A. Núñez Ortiz3, V. Cabello Rubio3, H. Pallarés Manrique1, E. Gómez Delgado1, A. Bejarano García1

Created: Friday, 22 February 2019, 9:41 AM
P762: Population Pharmacokinetic Model of Intravenous Infliximab in Korean Patients with Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Seo, J.(1)*;Lee, M.H.(2);Hong, H.(2);Oh, E.H.(3);Hwang, S.W.(1,4);Park, S.H.(1,4);Yang, D.H.(1);Byeon, J.S.(1);Myung, S.J.(1);Yang, S.K.(1,4);Bae, K.S.(2);Ye, B.D.(1,4);
Created: Friday, 14 July 2023, 11:12 AM
P763 Epstein–Barr virus serological status in paediatric patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Feo-Ortega, G. Pujol Muncunill, B. Minguez-Rodríguez, L. Álvarez-Carnero, L.N. Guevara-Caviedes, M.B. Coronel-Arismendi, V. Vila-Miravet, F.J. Martin De Carpi

Created: Thursday, 30 January 2020, 10:12 AM
P763: Addiction in IBD patients: more than just smoke?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Hirschmann1, J. Koehnen*1, B. Schuster2, R. Atreya1, N. Krauss3, J. Mudter4, M. Dauer5, A. Hagel6, M. F. Neurath1, H. Albrecht1,7

Created: Friday, 22 February 2019, 9:41 AM
P763: Fucosyltransferase 2 non-secretor status in Crohn's disease: a prospective observational analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Battat R.*1,2, Kopylov U.3, Afif W.1, Bessissow T.1, Byer J.4, Dionne S.1, Zelikovic E.4, Seidman E.1, Bitton A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P763: Quality of life in Paediatric inflammatory bowel disease Patient: How well do we understand patients?
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Kim, S. Park, Y. Kang, H. Koh

Created: Thursday, 21 February 2019, 9:14 AM
P763: Role of quality of life in patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kaltenbach, T.(1)*;Schulte, L.A.(1);Kranzeder, A.(2);Klaus, J.(1);Sularz, M.(1);
Created: Friday, 14 July 2023, 11:12 AM
P764 Phenotypic analysis of patients with inflammatory bowel disease: 23 year data of a centre in a South American country
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C.C. Páez Cancelado1, R. García Duperly2, J. Park3, R. López Panqueva4, E.E. Londoño Schimmer2, A.M. Rey Rubiano5, J.E. Padrón Mercado2, M. Mejía Arango4, A. Gómez Aldana1, R.J. Vallejo Madroñero1, B. Mendoza De Molano6

Created: Thursday, 30 January 2020, 10:12 AM
P764: Drug level thresholds in patients with Crohn’s disease on dose-intensified anti-TNF therapy predict intestinal wall healing for infliximab but not adalimumab
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Little*, H. Su, A. Friedman, S. Williams, P. Gibson, M. Ward, K. Taylor, M. Sparrow

Created: Thursday, 21 February 2019, 9:14 AM
P764: Effectiveness and safety of COVID-19 Vaccine among Patients with Inflammatory Bowel Disease: A medical center hospital-based study in central Taiwan
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wu, Y.H.(1)*;Chou, J.W.(2);Huang, P.J.(1);Wang, C.P.(1);Cheng, K.S.(1);
Created: Friday, 14 July 2023, 11:12 AM
P764: Prevalence of Autoimmune diseases among first- and second-degree relatives of patients with inflammatory bowel diseases. A case–control survey in Israel
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Khoury*1, A. Mari2, L. Mhamed3, M. Mahamid4

Created: Friday, 22 February 2019, 9:41 AM
P764: Response to thiopurines is independent of ATG16L1 genotype
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Verstockt B.*1,2, Matthias A.T.3, Strongili K.3, Cleynen I.4, Parkes M.3

Created: Wednesday, 20 February 2019, 10:36 AM